A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource

June 2021 Medicare Drug List Updates: Thirty-eight (38) medications added to 2021 Medicare Part D Drug plan formularies.

Category: Monthly Formulary Changes
Published: Jun, 25 2021 10:06:49

The recently released June 2021 Medicare Part D prescription drug plan formulary (drug lists) data is now online and included in our Formulary Browser and Q1Rx Drug Finder.

The June formulary updates include the addition of 38 new National Drug Codes (NDCs), representing 29 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).

Highlights of the June 2021 Formulary update include six (6) newly-added brand-name drugs

The June drug data updates include 20 new brand-name drugs, six (6) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • UKONIQ®, and
  • ZILXI®.

The June 2021 Formulary update includes five (5) newly-added generic drugs

The June Medicare Part D drug data also includes nine (9) new generic medications, five (5) of which are newly-introduced generic drugs.  These new generic drugs include:

You can see our article "June 2021 Drug List Updates: Nine (9) new generic drugs added to many Medicare Part D plan formularies." found at https://Q1News.com/899.html for more about coverage the new generics.

Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.

Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: https://Q1FAQ.com/155.html

Summary of June 2021 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 38 new June 2021 NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form and Strength2
New Drug16
New Drug and Strength14
New Manufacturer and Strength5
New Strength1
Grand Total38

The following chart details the 38 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.

NDC Drug Name Number of
PDP Formularies*
Number of
MAPD Formularies*
72143023230 ACCUTANE 20 MG CAPSULE [ZENATANE] 56 332 New Drug and Strength
72143023330 ACCUTANE 30 MG CAPSULE [ZENATANE] 54 332 New Drug and Strength
72143023430 ACCUTANE 40 MG CAPSULE [ZENATANE] 56 332 New Drug and Strength
42195084010 ACETAMN-CAF-DIHYDRCODEIN 320.5 CAPSULE [Trezix] 5 33 New Drug
10019098209 CYCLOPHOSPHAMIDE 25 MG TABLET [Cytoxan] 57 351 New Drug and Strength
10019098409 CYCLOPHOSPHAMIDE 50 MG TABLET [Cytoxan] 57 351 New Drug and Strength
51862051403 DESOGESTREL-EE 0.15-0.03 MG TABLET [Solia] 59 346 New Drug
67877070490 DROXIDOPA 100 MG CAPSULE [NORTHERA] 67 389 New Drug and Strength
67877070590 DROXIDOPA 200 MG CAPSULE [NORTHERA] 67 389 New Drug and Strength
67877070690 DROXIDOPA 300 MG CAPSULE [NORTHERA] 67 389 New Drug and Strength
24338011003 ERYTHROMYCIN ES 400 MG TABLET [E.E.S.] 40 228 New Drug
00037044267 FELBATOL 600 MG/5 ML ORAL SUSPENSION 0 4 New Delivery Form and Strength
73336007530 GEMTESA 75 MG TABLET 3 27 New Drug
00548585000 GLUCAGON 1 MG EMERGENCY KIT VIAL 41 251 New Drug
52427080390 GRALISE ER 300 MG TABLET ER 24H 3 60 New Drug and Strength
52427080690 GRALISE ER 600 MG TABLET ER 24H 3 60 New Drug and Strength
43068030406 HETLIOZ LQ 4 MG/ML ORAL SUSPENSION 17 127 New Delivery Form and Strength
13107000401 HYDROCODONE-IBUPROFEN 7.5-200 TABLET [Vicoprofen] 51 358 New Drug
00078074303 ILEVRO 0.3% OPHTH DROPS EYE DROPPER 45 319 New Drug
51672417406 IMIQUIMOD 3.75% CREAM PACK [Zyclara] 3 83 New Drug
69051030001 IMPAVIDO 50 MG CAPSULE 32 195 New Drug
68180090373 KAITLIB FE 0.8-0.025MG CHEWABLE TABLET [Layolis Fe] 23 185 New Drug
78670005096 LUCEMYRA 0.18 MG TABLET 3 129 New Drug
00069031301 MERREM IV 500 MG VIAL 3 8 New Drug
42195030809 NALFON 400 MG CAPSULE 0 4 New Strength
52268030201 NULYTELY SOLUTION RECON 14 94 New Drug
00406051201 OXYCODONE-ACETAMINOPHEN 5-325 TABLET [Roxicet] 68 398 New Drug
00169413013 OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN INJECTOR 62 368 New Manufacturer and Strength
80056014301 RELTONE 200 MG CAPSULE 0 5 New Drug and Strength
80056014401 RELTONE 400 MG CAPSULE 0 5 New Drug and Strength
00006672268 SINEMET 10-100 MG TABLET 3 8 New Manufacturer and Strength
00006672468 SINEMET 25-100 MG TABLET 3 8 New Manufacturer and Strength
78670013102 SYMJEPI 0.15 MG/0.3 ML SYRINGE 18 233 New Drug and Strength
78670013002 SYMJEPI 0.3 MG/0.3 ML SYRINGE 18 234 New Drug and Strength
73150020012 UKONIQ 200 MG TABLET 68 398 New Drug
73562020810 VIOKACE 20,880-78,300 UNIT TABLET 11 50 New Manufacturer and Strength
73562011601 ZENPEP DR 25,000 UNIT CAPSULE DR 57 363 New Manufacturer and Strength
72356010303 ZILXI 1.5% FOAM 0 1 New Drug

Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the Q1Medicare.com Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.

Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.